Jul 12 |
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
|
Jul 5 |
Monthly information on share capital and company voting rights
|
Jun 20 |
Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing
|
Jun 18 |
Cellectis Upgraded to Buy: Here's Why
|
Jun 18 |
Cellectis (CLLS) Upgraded to Buy: Here's Why
|
Jun 18 |
After Plunging -27.95% in 4 Weeks, Here's Why the Trend Might Reverse for Cellectis (CLLS)
|
Jun 12 |
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
|
May 30 |
Cellectis S.A. (CLLS) Q1 2024 Earnings Call Transcript
|
May 30 |
Cellectis: 2 Data Readouts Of Blood Cancer Studies By End Of 2024
|
May 29 |
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024
|